Indian Citalopram Exporters: Complete Supplier Ranking with Market Share — 257 Manufacturers (2026) — TransData Nexus

Q: Who is the largest citalopram supplier from India?

MEDISPRAY LABORATORIES PRIVATE LIMITED is the largest citalopram exporter from India with a 30.5% market share and export value of $77.6M.

Q: How many citalopram suppliers are there in India?

There are 257 active citalopram exporters in India, collectively shipping $254.5M worth of citalopram across 7,372 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top citalopram suppliers from India?

The top 5 citalopram suppliers from India — MEDISPRAY LABORATORIES PRIVATE LIMITED, AUROBINDO PHARMA LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED, TORRENT PHARMACEUTICALS LTD, MYLAN LABORATORIES LIMITED — together control 65.8% of total citalopram export value from India.

Suresh Sormare

Citalopram

India Pharmaceutical Trade Intelligence

$254.5M257 Suppliers101 CountriesHS 30049099

ExportsIndia → MOROCCO31.6%India → UNITED STATES28.8%

ImportsCANADA → India$5.3M UNITED STATES → India$24.9K

#1 Supplier: MEDISPRAY LABORATORIES #1 Buyer: CIPLA MAROC

Citalopram Suppliers from India (2026) — 257 Exporters, $254.5M Market | TransData Nexus | TransData Nexus

Who Exports Citalopram from India — 257 Suppliers Behind a $254.5M Market

India's citalopram export market is supplied by 257 active exporters who collectively shipped $254.5M across 7,372 shipments. MEDISPRAY LABORATORIES PRIVATE LIMITED leads with a 30.5% market share, followed by AUROBINDO PHARMA LTD and SUN PHARMACEUTICAL INDUSTRIES LIMITED. The top 5 suppliers together control 65.8% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Citalopram Suppliers & Exporters — 257 manufacturers, $254.5M export market, top destinations and formulations — Citalopram supplier data — 257 exporters · $254.5M market · 7,372 shipmentsTransData Nexus · Indian Customs Data

Top Citalopram Exporters from India — Ranked by Export Value

MEDISPRAY LABORATORIES PRIVATE LIMITED is the leading citalopram exporter from India, holding a 30.5% share of the $254.5M market across 7,372 shipments from 257 exporters. The top 5 suppliers — MEDISPRAY LABORATORIES PRIVATE LIMITED, AUROBINDO PHARMA LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED, TORRENT PHARMACEUTICALS LTD, MYLAN LABORATORIES LIMITED — collectively control 65.8% of total export value, indicating a moderately concentrated market. Individual shares are: MEDISPRAY LABORATORIES PRIVATE LIMITED (30.5%), AUROBINDO PHARMA LTD (11.0%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (9.0%), TORRENT PHARMACEUTICALS LTD (8.5%), MYLAN LABORATORIES LIMITED (6.8%).

Top Citalopram Exporters from India

Ranked by export value · 257 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Citalopram Exporters from India — Ranked by Export Value. 257 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Citalopram — Export Intelligence Video

Visual overview of India's citalopram supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's citalopram pharmaceutical supplier landscape — $254.5M in total trade, 257 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Citalopram exporters

Certification and compliance status for top Citalopram suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Aurobindo Pharma Limited	Approved	Yes	Yes	Multiple	FDA warning letter issued on June 20, 2019, for Pydibhimavaram facility.
Sun Pharmaceutical Industries Limited	Approved	Yes	Yes	Multiple	No FDA warning letters found.
Torrent Pharmaceuticals Limited	Approved	Yes	Yes	Multiple	FDA warning letter issued in May 2011; specific facility not detailed.
Mylan Laboratories Limited	Approved	Yes	Yes	Multiple	No FDA warning letters found.
Cipla Limited	Approved	Yes	Yes	Multiple	No FDA warning letters found.
Intas Pharmaceuticals Limited	Approved	Yes	Yes	Multiple	No FDA warning letters found.
Micro Labs Limited	Approved	Yes	Yes	Multiple	No FDA warning letters found.
Apotex Research Private Limited	Approved	Yes	Yes	Multiple	No FDA warning letters found.

TransData Nexus reviewed the regulatory standing of 8 leading Citalopram exporters from India. 8 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Citalopram sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as India's "Bulk Drug Capital," is a pivotal hub for Active Pharmaceutical Ingredients (APIs) and bulk drug manufacturing. The city hosts over 800 pharmaceutical companies, including major players like Dr. Reddy's Laboratories and Aurobindo Pharma. The presence of Genome Valley, India's first biotech cluster, underscores Hyderabad's emphasis on research and development in the pharmaceutical sector.

The city's robust infrastructure, skilled workforce, and supportive government policies have fostered a conducive environment for pharmaceutical manufacturing. Hyderabad's strategic location and well-established supply chain networks further enhance its appeal for API production and export activities.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations manufacturing. Gujarat contributes nearly 28% of India's pharmaceutical production, with over 3,300 pharmaceutical units operating in the state. Companies such as Zydus Cadila, Intas Pharmaceuticals, and Torrent Pharmaceuticals have established significant operations in this region.

The region's well-developed infrastructure, including proximity to major ports, facilitates efficient export operations. Additionally, the presence of a skilled workforce and a favorable regulatory environment make Ahmedabad and Vadodara attractive destinations for pharmaceutical manufacturing and export.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Citalopram exporters from India

March 2025

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

In March 2025, Sun Pharma announced the acquisition of Checkpoint Therapeutics, a Waltham, Massachusetts-based company specializing in immunotherapy and targeted oncology treatments, for $355 million. IMPACT: This acquisition is expected to enhance Sun Pharma's oncology portfolio, potentially influencing its strategic focus and resource allocation, which may indirectly affect its Citalopram export activities.

Impact: This acquisition is expected to enhance Sun Pharma's oncology portfolio, potentially influencing its strategic focus and resource allocation, which may indirectly affect its Citalopram export activities.

January 2024

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma merges with Taro Pharmaceuticals in $347.73 million deal

In January 2024, Sun Pharma entered into a definitive merger agreement with Taro Pharmaceuticals, acquiring the remaining stake for $347.73 million. This move aimed to consolidate Sun Pharma's position in the generic pharmaceutical market. IMPACT: The merger is likely to strengthen Sun Pharma's market presence, potentially impacting its production and export strategies, including those related to Citalopram.

Common Questions — Citalopram Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which citalopram supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, MEDISPRAY LABORATORIES PRIVATE LIMITED leads with 77 recorded shipments worth $77.6M. AUROBINDO PHARMA LTD (1,035 shipments) and SUN PHARMACEUTICAL INDUSTRIES LIMITED (463 shipments) are also established high-volume exporters.

Q How many citalopram manufacturers are there in India?

India has 257 active citalopram exporters with a combined export market of $254.5M across 7,372 shipments to 101 countries. The top 5 suppliers hold 65.8% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for citalopram from India?

Average FOB unit price: $3.57 per unit, ranging from $0.00 to $978.18. Average shipment value: $34.5K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Citalopram

Citalopram

Who Exports Citalopram from India — 257 Suppliers Behind a $254.5M Market

Top Citalopram Exporters from India — Ranked by Export Value

Top Citalopram Exporters from India

Related Analysis

Need Details?

Citalopram — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

Recent M&A, Collaborations & Capacity Expansions

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Sun Pharmaceutical Industries Limited — Sun Pharma merges with Taro Pharmaceuticals in $347.73 million deal

Common Questions — Citalopram Suppliers from India

Q Which citalopram supplier from India is the most reliable for bulk orders?

Q How many citalopram manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for citalopram from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Mumbai-Thane-Raigad — Export Gateway

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Sun Pharmaceutical Industries Limited — Sun Pharma partners with Pharmazz for ischemic stroke drug in India

Analysis Methodology